India Asthma Inhaler Device Market

ID: MRFR/HC/54556-HCR 200 Pages Nidhi Mandole Last Updated: September 17, 2026
India Asthma Inhaler Device Market Research Report: By Type (Metered Dose Inhalers, Dry Powder Inhalers, Soft Mist Inhalers), By Mode of Operation (Manually Operated Inhaler Devices, Digitally-Operated Inhaler Devices) andBy End User (Hospitals & Clinics, Homecare)- Forecast to 2035
India Asthma Inhaler Device Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)7.97%
2018 Market Size$ 77 Million
2024 Market Size$ 75.6 Million
2035 Market Size$ 175.7 Million
Key Players
Cipla
Sun Pharmaceutical Industries
Dr. Reddy's Laboratories
GlaxoSmithKline
Novartis
Boehringer Ingelheim
Trends
  • Rising Awareness and Education
  • Technological Advancements in Devices
  • Personalized Treatment Approaches
Opportunities
  • Rising Healthcare Expenditure
  • Increasing Prevalence of Asthma
  • Government Initiatives and Policies
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 India Asthma Inhaler Device Market, BY Device Type (USD Million)
      1. 4.1.1 Metered Dose Inhaler
      2. 4.1.2 Dry Powder Inhaler
      3. 4.1.3 Nebulizer
      4. 4.1.4 Soft Mist Inhaler
    2. 4.2 India Asthma Inhaler Device Market, BY Age Group (USD Million)
      1. 4.2.1 Children
      2. 4.2.2 Adults
      3. 4.2.3 Elderly
    3. 4.3 India Asthma Inhaler Device Market, BY Usage Frequency (USD Million)
      1. 4.3.1 Daily
      2. 4.3.2 Weekly
      3. 4.3.3 Occasional
      4. 4.3.4 Emergency
    4. 4.4 India Asthma Inhaler Device Market, BY Distribution Channel (USD Million)
      1. 4.4.1 Pharmacies
      2. 4.4.2 Online Retail
      3. 4.4.3 Hospitals
      4. 4.4.4 Clinics
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the India Asthma Inhaler Device Market
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the India Asthma Inhaler Device Market
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Cipla (IN)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Sun Pharmaceutical Industries (IN)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Dr. Reddy's Laboratories (IN)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 GlaxoSmithKline (GB)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Novartis (CH)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Boehringer Ingelheim (DE)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Teva Pharmaceutical Industries (IL)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Mylan (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 AstraZeneca (GB)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 INDIA MARKET ANALYSIS BY DEVICE TYPE
    3. 6.3 INDIA MARKET ANALYSIS BY AGE GROUP
    4. 6.4 INDIA MARKET ANALYSIS BY USAGE FREQUENCY
    5. 6.5 INDIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    6. 6.6 KEY BUYING CRITERIA OF INDIA ASTHMA INHALER DEVICE MARKET
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF INDIA ASTHMA INHALER DEVICE MARKET
    9. 6.9 DRIVERS IMPACT ANALYSIS: INDIA ASTHMA INHALER DEVICE MARKET
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: INDIA ASTHMA INHALER DEVICE MARKET
    11. 6.11 SUPPLY / VALUE CHAIN: INDIA ASTHMA INHALER DEVICE MARKET
    12. 6.12 INDIA ASTHMA INHALER DEVICE MARKET, BY DEVICE TYPE, 2024 (% SHARE)
    13. 6.13 INDIA ASTHMA INHALER DEVICE MARKET, BY DEVICE TYPE, 2024 TO 2035 (USD Million)
    14. 6.14 INDIA ASTHMA INHALER DEVICE MARKET, BY AGE GROUP, 2024 (% SHARE)
    15. 6.15 INDIA ASTHMA INHALER DEVICE MARKET, BY AGE GROUP, 2024 TO 2035 (USD Million)
    16. 6.16 INDIA ASTHMA INHALER DEVICE MARKET, BY USAGE FREQUENCY, 2024 (% SHARE)
    17. 6.17 INDIA ASTHMA INHALER DEVICE MARKET, BY USAGE FREQUENCY, 2024 TO 2035 (USD Million)
    18. 6.18 INDIA ASTHMA INHALER DEVICE MARKET, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
    19. 6.19 INDIA ASTHMA INHALER DEVICE MARKET, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 India MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY DEVICE TYPE, 2026-2035 (USD Million)
      2. 7.2.2 BY AGE GROUP, 2026-2035 (USD Million)
      3. 7.2.3 BY USAGE FREQUENCY, 2026-2035 (USD Million)
      4. 7.2.4 BY DISTRIBUTION CHANNEL, 2026-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

India Asthma Inhaler Device Market Segmentation

India Asthma Inhaler Device Market By Device Type (USD Million, 2022-2035)

  • Metered Dose Inhaler
  • Dry Powder Inhaler
  • Nebulizer
  • Soft Mist Inhaler

India Asthma Inhaler Device Market By Age Group (USD Million, 2022-2035)

  • Children
  • Adults
  • Elderly

India Asthma Inhaler Device Market By Usage Frequency (USD Million, 2022-2035)

  • Daily
  • Weekly
  • Occasional
  • Emergency

India Asthma Inhaler Device Market By Distribution Channel (USD Million, 2022-2035)

  • Pharmacies
  • Online Retail
  • Hospitals
  • Clinics

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.